|
DE19602964A1
(en)
*
|
1995-12-20 |
1997-07-31 |
Nycomed Arzneimittel Gmbh |
New morphine derivatives
|
|
DE60224288T2
(en)
*
|
2002-11-25 |
2009-04-16 |
Chi Mei Foundation Medical Center |
Buprenorphine ester derivatives, processes for their preparation, and long-acting analgesic drugs
|
|
KR100704085B1
(en)
*
|
2002-12-02 |
2007-04-05 |
치 메이 파운데이션 메디칼 센터 |
Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions
|
|
US20050053659A1
(en)
|
2003-09-10 |
2005-03-10 |
Pace Gary W. |
Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
|
|
US20080119820A1
(en)
|
2006-09-20 |
2008-05-22 |
Phan Phillip C |
Methods for Delivering Volatile Anesthetics for Regional Anesthesia and/or Pain Relief
|
|
JP5789100B2
(en)
|
2008-01-22 |
2015-10-07 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
Volatile anesthetic composition for local anesthesia and / or pain reduction comprising extraction solvent
|
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
|
CA2765836C
(en)
*
|
2009-07-02 |
2014-10-07 |
Kempharm, Inc. |
Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
|
|
US10849981B2
(en)
|
2009-07-02 |
2020-12-01 |
KemPham, Inc. |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
|
|
UA102916C2
(en)
*
|
2009-07-02 |
2013-08-27 |
Кемфарм, Інк. |
Composition based on conjugates of hydrocodone with benzoic acid, benzoic acid or heteroaryl carboxylic acid derivatives, prodrugs and method for treatment of abuses
|
|
EP2353598A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for use in the prevention and/or treatment of postoperative pain
|
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
|
US20120076865A1
(en)
|
2010-03-24 |
2012-03-29 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
|
EP2524694A1
(en)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
|
JP2016540771A
(en)
|
2013-12-17 |
2016-12-28 |
ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ |
Combination of serotonin-noradrenaline reuptake inhibitor (SNRI) and sigma receptor ligand
|
|
JP6400848B2
(en)
|
2014-11-25 |
2018-10-03 |
ケムファーム・インコーポレーテッド |
Benzoic acid, benzoic acid derivatives and heteroarylcarboxylic acid conjugates of oxycodone
|
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
UY37341A
(en)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
|
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US20180263936A1
(en)
|
2017-03-17 |
2018-09-20 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
WO2020012248A1
(en)
|
2018-07-13 |
2020-01-16 |
Alkermes Pharma Ireland Limited |
Novel naphthylenyl compounds for long-acting injectable compositions and related methods
|
|
WO2020012245A1
(en)
|
2018-07-13 |
2020-01-16 |
Alkermes Pharma Ireland Limited |
Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
|
|
US10975099B2
(en)
|
2018-11-05 |
2021-04-13 |
Alkermes Pharma Ireland Limited |
Thiophene compounds for long-acting injectable compositions and related methods
|
|
AU2019383389A1
(en)
|
2018-11-19 |
2021-05-06 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|
|
CA3127871A1
(en)
|
2019-03-01 |
2020-09-10 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
WO2023164889A1
(en)
*
|
2022-03-03 |
2023-09-07 |
暨南大学 |
Method for preparing codeine and derivative and intermediate thereof
|